Delos Capital

Delos Capital is a New York-based private equity firm founded in 2013 that specializes in management buyouts, recapitalizations, and growth investments primarily targeting lower middle market companies across the United States[1][4]. The firm’s mission centers on delivering tailored investment solutions by leveraging deep industry expertise and close collaboration with management teams to maximize alignment and outcomes[3]. Delos Capital’s investment philosophy emphasizes complex, cutting-edge transactions where their involvement can add significant value, focusing on sectors where they can drive growth and operational improvements. While the firm broadly invests across industries, its portfolio includes companies in healthcare and life sciences, reflecting a commitment to supporting innovations that improve patient outcomes[2]. Delos Capital plays a meaningful role in the startup and growth ecosystem by providing capital and strategic guidance that enable companies to scale and innovate.

Delos Capital was co-founded by Managing Partners Matt Constantino and Andrew Schweibold, both bringing decades of experience in private equity and financial advisory[5]. Schweibold, who returned to the firm in 2024, has a background with Apollo Global Management and Lazard, while Ari Lefkovits, another Managing Partner who joined in 2024, has extensive experience in capital solutions and restructuring from his time at Lazard[5]. Alice Chong and Jay Losty round out the leadership team, bringing expertise in restructuring, M&A, and complex financing[5]. The firm has evolved to focus on lower middle market companies, leveraging its founders’ deep networks and transaction experience to identify and support promising businesses[4].

Core Differentiators

• Unique Investment Model: Focus on complex, tailored transactions such as management buyouts and recapitalizations that require specialized expertise[1][3].
• Experienced Leadership: Partners with 20+ years of institutional investment and advisory experience from top firms like Apollo, Lazard, and Guggenheim[5].
• Network Strength: Strong connections across private equity, investment banking, and operational leadership to support portfolio companies.
• Track Record: Multiple closed funds targeting lower middle market companies, demonstrating consistent capital deployment and strategic focus[4].
• Operating Support: Hands-on partnership approach with management teams to drive growth and operational improvements[3].

Role in the Broader Tech and Investment Landscape

Delos Capital operates at the intersection of private equity and growth investing during a period when lower middle market companies are increasingly attractive due to their growth potential and need for capital and operational expertise. The firm benefits from market forces such as increased demand for specialized capital solutions and a growing emphasis on innovation in healthcare and technology sectors[2]. By focusing on complex transactions, Delos Capital fills a niche that larger funds may overlook, thus influencing the broader ecosystem by enabling mid-sized companies to scale and innovate effectively.

Quick Take & Future Outlook

Looking ahead, Delos Capital is poised to continue leveraging its deep expertise and network to capitalize on opportunities in the lower middle market, particularly in sectors like life sciences where innovation is accelerating[2]. Trends such as increased healthcare innovation, demand for specialized financing, and the evolving needs of mid-sized companies will shape their investment strategy. As the firm expands its portfolio and influence, it may deepen its role as a key enabler of growth-stage companies, potentially broadening its sector focus while maintaining its core strength in complex, value-added investments.

This positions Delos Capital as a dynamic private equity firm that combines seasoned leadership with a strategic focus on transformative investments, driving impact across the companies it partners with and the broader market.